1457 |
138 |
105 | |||
108 |
73 |
5 |
Total: 1895 |
ARC is a foundation in Australia that is licensed and certified in purpose-genetic breeding.
Their industry-leading facility has provided the world with genetically modified (GM) species, advancing ethical and legislative developments in transplantation. They focus on clinical applications, specifically kidney and islet cell xenotransplantation.
 | Our VisionTo provide optimal care for individuals with diabetes through exemplary education, research, and clinical housing services.
Development & ImprovementWe will work together to identify areas for improvement in our foundation. We are committed to enhancing our research and clinical services to uphold high service standards. We prioritise the care and welfare of all herd species above standard industry practices. Your feedback is always appreciated. |
| “After receiving the GM subjects, we developed a technology that allows us to blend the pancreas and extract the islet cells. This procedure is quite complex and usually takes between 8 to 10 hours. At the end of the process, we obtain well-separated islet cells. The beauty of this is that we can potentially expand the number of patients who can receive islets from human donors” Westmead Hospital Institute Research Centre | "Wisemind Medical commends the ARC Foundation for its substantial support of research and clinical initiatives in kidney transplantation. The ARC Foundation's commitment has been instrumental in advancing groundbreaking studies that improve outcomes for patients with diabetic kidney disease."
| "We have achieved substantial growth with ARC Foundation and have observed increased market interest following the recent changes we implemented. ARC Foundation has allowed us to provide information that is more timely, relevant, targeted, and demonstrably beneficial for our participants." NEXGEN GROUP
|
